Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news



EFSA rejects Naturex and Pharmachem cranberry-UTI claims

By Shane Starling+

Last updated on 09-May-2014 at 00:15 GMT2014-05-09T00:15:24Z

Naturex: "“We will continue to pursue permissible health claims in other countries..."

Naturex and Pharmachem are the latest cranberry players to be rebuffed by the EU’s central science agency. In the first, it this week failed French botanical giant Naturex's urinary tract infection (UTI) dossier containing a key study it said, showed no effect”.

Naturex, which acquired the ‘Pacran’ extract in question from Decas Botanical Synergies in 2012, said it stood behind the claim and would turn its focus to other parts of the world – for now.

“We stand behind Pacran’s robust clinical evidence,” said Naturex marketing director, Antoine Dauby, who noted an approved claim by the Korean Food and Drug Administration (KFDA).

“We will continue to pursue permissible health claims in other countries and to help women suffering from recurrent UTIs in Europe and the rest of the world.”

EFSA’s Panel on Dietetic Products, Nutrition and Allergies (NDA) concluded Pacran did not act, “against bacterial pathogens in the lower urinary tract.”

The article 13.5 emerging and proprietary science opinion can be found here .

CranMax axed

It wasn’t the only cranberry dossier rejected by the NDA. Danish pharma and supplements manufacturer Jemo-pharm A/S also had an article 13.5 claim rejected based on a CranMax extract for the same UTI condition.

One human study from which conclusions could be drawn for the scientific substantiation of the claim did not show an effect of CranMax on reduction of the risk of urinary tract infection by inhibiting the adhesion of certain bacteria in the urinary tract,” the panel said.

CranMax is manufactured by New Jersey supplier Pharmachem. The company couldn’t be contacted at the time of publication.

The opinion can be found here .

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars